BSX Boston Scientific
NYSE · SEC CIK 885725 · EDGAR
- Bought, last 12 months
- $10.04M 8 purchases by 5 insiders
- Sold, last 12 months
- $29.27M 6 sales by 4 insiders
- Filings on record
- 526 since 2021-07-06, latest 2026-09-03 16:34
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Mahoney Michael F | COB, Pres, CEO, Dir | $9.00M | $15.04M |
| Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | — | $9.90M |
| Zane Ellen M | Dir | — | $2.57M |
| Butcher Arthur C | EVP, Grp Pres, MedSurg, APAC | — | $1.76M |
| LUDWIG EDWARD J | Dir | $430.3K | — |
| Habiger David C | Dir | $407.9K | — |
| Morano Susan E | Dir | $100.4K | — |
| Pegus Cheryl | Dir | $100.0K | — |
| O'Connor Padraig Andrew | EVP, Gbl Ops | — | — |
| O'Sullivan Miriam | SVP, Chief HR Off | — | — |
Transactions 847
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-02-21 | 2023-02-16+ | BSX | Sorenson John Bradley | EVP, Gbl Ops | F - Tax | $46.52 | -1,807 | 36.4K | -5% | -$84.1K |
| DM | 2023-02-21 | 2023-02-16+ | BSX | Sorenson John Bradley | EVP, Gbl Ops | M - OptEx | $0.00 | +3,958 | 37.9K | +12% | $0 |
| DM | 2023-02-21 | 2023-02-16+ | BSX | Mahoney Michael F | COB, Pres, CEO, Dir | M - OptEx | $0.00 | +50.9K | 1.84M | +3% | $0 |
| DM | 2023-02-21 | 2023-02-16+ | BSX | Mahoney Michael F | COB, Pres, CEO, Dir | F - Tax | $46.52 | -22.6K | 1.82M | -1% | -$1.05M |
| DM | 2023-02-21 | 2023-02-16+ | BSX | Brown Vance R | SVP, GC, Corp. Sec | M - OptEx | $0.00 | +3,579 | 40.4K | +10% | $0 |
| DM | 2023-02-21 | 2023-02-16+ | BSX | Brown Vance R | SVP, GC, Corp. Sec | F - Tax | $46.51 | -1,080 | 39.9K | -3% | -$50.2K |
| DM | 2023-02-21 | 2023-02-16+ | BSX | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | M - OptEx | $0.00 | +11.8K | 216.1K | +6% | $0 |
| DM | 2023-02-21 | 2023-02-16+ | BSX | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | F - Tax | $46.52 | -5,691 | 218.3K | -3% | -$264.8K |
| DM | 2023-02-21 | 2023-02-16+ | BSX | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | F - Tax | $46.52 | -2,931 | 91.9K | -3% | -$136.4K |
| DM | 2023-02-21 | 2023-02-16+ | BSX | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | M - OptEx | $0.00 | +9,120 | 92.9K | +11% | $0 |
| DM | 2023-02-21 | 2023-02-16+ | BSX | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | S - Sale+OE | $46.53 | -3,470 | 90.5K | -4% | -$161.5K |
| DM | 2023-02-21 | 2023-02-16+ | BSX | Thepaut Eric Francis Yves | EVP, Pres, Eur, Mid-East, Afr | F - Tax | $46.51 | -2,758 | 62.4K | -4% | -$128.3K |
| DM | 2023-02-21 | 2023-02-16+ | BSX | Thepaut Eric Francis Yves | EVP, Pres, Eur, Mid-East, Afr | M - OptEx | $0.00 | +4,762 | 63.7K | +8% | $0 |
| D | 2023-02-16 | 2023-02-15 | BSX | Butcher Arthur C | EVP, Grp Pres, MedSurg, APAC | F - Tax | $47.29 | -819 | 24.4K | -3% | -$38.7K |
| D | 2023-02-16 | 2023-02-15 | BSX | Butcher Arthur C | EVP, Grp Pres, MedSurg, APAC | M - OptEx | $0.00 | +1,846 | 25.2K | +8% | $0 |
| D | 2023-02-16 | 2023-02-15 | BSX | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | M - OptEx | $0.00 | +4,615 | 214.4K | +2% | $0 |
| D | 2023-02-16 | 2023-02-15 | BSX | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | F - Tax | $47.29 | -2,488 | 212.0K | -1% | -$117.7K |
| D | 2023-02-16 | 2023-02-15 | BSX | Monson Jonathan | SVP, CAO, Gbl Ctrl | F - Tax | $47.29 | -340 | 33.0K | -1% | -$16.1K |
| D | 2023-02-16 | 2023-02-15 | BSX | Monson Jonathan | SVP, CAO, Gbl Ctrl | M - OptEx | $0.00 | +739 | 33.3K | +2% | $0 |
| D | 2023-02-16 | 2023-02-15 | BSX | Brennan Daniel J. | EVP, CFO | F - Tax | $47.29 | -1,219 | 283.9K | -0.4% | -$57.6K |
| D | 2023-02-16 | 2023-02-15 | BSX | Brennan Daniel J. | EVP, CFO | S - Sale+OE | $47.14 | -7,572 | 276.3K | -3% | -$356.9K |
| DM | 2023-02-16 | 2023-02-15 | BSX | Brennan Daniel J. | EVP, CFO | M - OptEx | $4.77 | +11.7K | 285.1K | +4% | +$56.0K |
| D | 2023-02-16 | 2023-02-15 | BSX | Sorenson John Bradley | EVP, Gbl Ops | M - OptEx | $0.00 | +1,200 | 36.2K | +3% | $0 |
| D | 2023-02-16 | 2023-02-15 | BSX | Sorenson John Bradley | EVP, Gbl Ops | F - Tax | $47.29 | -548 | 35.7K | -2% | -$25.9K |
| D | 2023-02-16 | 2023-02-15 | BSX | Carruthers Wendy | EVP, Human Resources | F - Tax | $47.29 | -737 | 89.6K | -0.8% | -$34.9K |
| D | 2023-02-16 | 2023-02-15 | BSX | Carruthers Wendy | EVP, Human Resources | M - OptEx | $0.00 | +1,661 | 90.3K | +2% | $0 |
| D | 2023-02-16 | 2023-02-15 | BSX | Mahoney Michael F | COB, Pres, CEO, Dir | F - Tax | $47.29 | -8,186 | 1.81M | -0.4% | -$387.1K |
| D | 2023-02-16 | 2023-02-15 | BSX | Mahoney Michael F | COB, Pres, CEO, Dir | M - OptEx | $0.00 | +18.5K | 1.82M | +1% | $0 |
| D | 2023-02-16 | 2023-02-15 | BSX | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | F - Tax | $47.29 | -622 | 89.9K | -0.7% | -$29.4K |
| D | 2023-02-16 | 2023-02-15 | BSX | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | M - OptEx | $0.00 | +2,031 | 90.5K | +2% | $0 |
| D | 2023-02-16 | 2023-02-15 | BSX | Brown Vance R | SVP, GC, Corp. Sec | F - Tax | $47.29 | -323 | 38.6K | -0.8% | -$15.3K |
| D | 2023-02-16 | 2023-02-15 | BSX | Brown Vance R | SVP, GC, Corp. Sec | M - OptEx | $0.00 | +923 | 38.9K | +2% | $0 |
| D | 2023-02-16 | 2023-02-15 | BSX | Thepaut Eric Francis Yves | EVP, Pres, Eur, Mid-East, Afr | M - OptEx | $0.00 | +1,846 | 62.5K | +3% | $0 |
| D | 2023-02-16 | 2023-02-15 | BSX | Thepaut Eric Francis Yves | EVP, Pres, Eur, Mid-East, Afr | F - Tax | $47.29 | -1,069 | 61.4K | -2% | -$50.6K |
| DM | 2023-02-15 | 2023-02-09+ | BSX | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | G - Gift | $0.00 | -13.5K | 209.8K | -6% | $0 |
| DI | 2023-02-15 | 2023-02-09 | BSX | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | G - Gift | $0.00 | +630 | 4,344 | +17% | $0 |
| D | 2023-02-15 | 2023-02-06 | BSX | Sorenson John Bradley | EVP, Gbl Ops | G - Gift | $0.00 | -4,779 | 35.0K | -12% | $0 |
| D | 2023-02-15 | 2023-02-10 | BSX | Carruthers Wendy | EVP, Human Resources | G - Gift | $0.00 | -2,195 | 88.7K | -2% | $0 |
| DM | 2023-02-06 | 2023-02-03 | BSX | Butcher Arthur C | EVP, Grp Pres, MedSurg, APAC | M - OptEx | $16.58 | +15.0K | 50.4K | +43% | +$249.2K |
| D | 2023-02-06 | 2023-02-03 | BSX | Butcher Arthur C | EVP, Grp Pres, MedSurg, APAC | S - Sale+OE | $48.74 | -27.0K | 23.4K | -54% | -$1.32M |
| 2023-01-04 | 2023-01-04 | BSX | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | S - Sale | $46.38 | -6,751 | 88.5K | -7% | -$313.1K | |
| D | 2023-01-03 | 2023-01-01 | BSX | Carruthers Wendy | EVP, Human Resources | M - OptEx | $0.00 | +6,567 | 94.0K | +8% | $0 |
| D | 2023-01-03 | 2023-01-01 | BSX | Carruthers Wendy | EVP, Human Resources | F - Tax | $46.27 | -3,100 | 90.9K | -3% | -$143.4K |
| D | 2023-01-03 | 2023-01-01 | BSX | Thepaut Eric Francis Yves | EVP, Pres, Eur, Mid-East, Afr | M - OptEx | $0.00 | +7,092 | 64.6K | +12% | $0 |
| D | 2023-01-03 | 2023-01-01 | BSX | Thepaut Eric Francis Yves | EVP, Pres, Eur, Mid-East, Afr | F - Tax | $46.27 | -3,988 | 60.6K | -6% | -$184.5K |
| D | 2023-01-03 | 2023-01-01 | BSX | Mahoney Michael F | COB, Pres, CEO, Dir | F - Tax | $46.27 | -22.6K | 1.80M | -1% | -$1.04M |
| D | 2023-01-03 | 2023-01-01 | BSX | Mahoney Michael F | COB, Pres, CEO, Dir | M - OptEx | $0.00 | +57.8K | 1.83M | +3% | $0 |
| D | 2023-01-03 | 2023-01-01 | BSX | Butcher Arthur C | EVP, Grp Pres, MedSurg, APAC | M - OptEx | $0.00 | +8,405 | 39.3K | +27% | $0 |
| D | 2023-01-03 | 2023-01-01 | BSX | Butcher Arthur C | EVP, Grp Pres, MedSurg, APAC | F - Tax | $46.27 | -3,904 | 35.4K | -10% | -$180.6K |
| D | 2023-01-03 | 2023-01-01 | BSX | Sorenson John Bradley | EVP, Gbl Ops | F - Tax | $46.27 | -1,463 | 39.8K | -4% | -$67.7K |
| D | 2023-01-03 | 2023-01-01 | BSX | Sorenson John Bradley | EVP, Gbl Ops | M - OptEx | $0.00 | +4,202 | 41.2K | +11% | $0 |
| D | 2023-01-03 | 2023-01-01 | BSX | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | M - OptEx | $0.00 | +9,981 | 98.5K | +11% | $0 |
| D | 2023-01-03 | 2023-01-01 | BSX | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | F - Tax | $46.27 | -3,230 | 95.2K | -3% | -$149.5K |
| D | 2023-01-03 | 2023-01-01 | BSX | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | M - OptEx | $0.00 | +13.1K | 230.0K | +6% | $0 |
| D | 2023-01-03 | 2023-01-01 | BSX | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | F - Tax | $46.27 | -6,658 | 223.3K | -3% | -$308.1K |
| D | 2023-01-03 | 2023-01-01 | BSX | Brennan Daniel J. | EVP, CFO | M - OptEx | $0.00 | +13.1K | 277.4K | +5% | $0 |
| D | 2023-01-03 | 2023-01-01 | BSX | Brennan Daniel J. | EVP, CFO | F - Tax | $46.27 | -4,042 | 273.4K | -1% | -$187.0K |
| 2022-12-15 | 2022-12-15 | BSX | Carruthers Wendy | EVP, Human Resources | S - Sale | $46.62 | -7,500 | 87.4K | -8% | -$349.6K | |
| D | 2022-12-14 | 2022-12-13 | BSX | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | S - Sale+OE | $47.78 | -79.3K | 216.9K | -27% | -$3.79M |
| D | 2022-12-14 | 2022-07-29 | BSX | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | G - Gift | $0.00 | -1,000 | 216.9K | -0.5% | $0 |
| D | 2022-12-14 | 2022-12-13 | BSX | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | M - OptEx | $7.39 | +79.3K | 296.1K | +37% | +$585.8K |
| 2022-12-13 | 2022-12-12 | BSX | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | S - Sale | $46.75 | -11.1K | 88.5K | -11% | -$518.0K | |
| D | 2022-12-12 | 2022-12-09 | BSX | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | S - Sale+OE | $46.15 | -41.0K | 99.6K | -29% | -$1.89M |
| D | 2022-12-12 | 2022-12-09 | BSX | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | M - OptEx | $13.08 | +29.6K | 140.6K | +27% | +$387.2K |
| DM | 2022-12-05 | 2022-05-16+ | BSX | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | G - Gift | $0.00 | -256 | 110.6K | -0.2% | $0 |
| D | 2022-12-05 | 2022-12-03 | BSX | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | F - Tax | $46.60 | -296 | 111.0K | -0.3% | -$13.8K |
| D | 2022-12-05 | 2022-12-03 | BSX | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | M - OptEx | $0.00 | +649 | 111.3K | +0.6% | $0 |
| I | 2022-11-30 | 2022-11-29 | BSX | Connors Nelda J | Dir | S - Sale | $44.47 | -18.2K | 27.2K | -40% | -$809.2K |
| 2022-11-21 | 2022-11-18 | BSX | Thepaut Eric Francis Yves | EVP, Pres, Eur, Mid-East, Afr | S - Sale | $42.72 | -15.0K | 57.5K | -21% | -$638.7K | |
| 2022-11-15 | 2022-11-15 | BSX | Carruthers Wendy | EVP, Human Resources | S - Sale | $42.60 | -1,678 | 94.9K | -2% | -$71.5K | |
| DM | 2022-11-08 | 2022-11-07 | BSX | Mahoney Michael F | COB, Pres, CEO, Dir | M - OptEx | $9.35 | +125.8K | 1.85M | +7% | +$1.18M |
| D | 2022-11-08 | 2022-11-07 | BSX | Mahoney Michael F | COB, Pres, CEO, Dir | S - Sale+OE | $41.97 | -125.8K | 1.77M | -7% | -$5.28M |
| 2022-10-18 | 2022-10-17 | BSX | Carruthers Wendy | EVP, Human Resources | S - Sale | $40.52 | -13.3K | 96.6K | -12% | -$539.8K | |
| DM | 2022-10-04 | 2022-10-03 | BSX | Mahoney Michael F | COB, Pres, CEO, Dir | M - OptEx | $9.35 | +125.8K | 1.85M | +7% | +$1.18M |
| D | 2022-10-04 | 2022-10-03 | BSX | Mahoney Michael F | COB, Pres, CEO, Dir | S - Sale+OE | $39.34 | -125.8K | 1.77M | -7% | -$4.95M |
| D | 2022-10-04 | 2022-10-02 | BSX | Brown Vance R | SVP, GC, Corp. Sec | M - OptEx | $0.00 | +3,394 | 39.0K | +10% | $0 |
| D | 2022-10-04 | 2022-10-02 | BSX | Brown Vance R | SVP, GC, Corp. Sec | F - Tax | $38.73 | -997 | 38.0K | -3% | -$38.6K |
| 2022-09-16 | 2022-09-15 | BSX | Carruthers Wendy | EVP, Human Resources | S - Sale | $42.21 | -7,500 | 109.9K | -6% | -$316.6K | |
| D | 2022-09-07 | 2022-08-30 | BSX | Mahoney Michael F | COB, Pres, CEO, Dir | G - Gift | $0.00 | -365.5K | 1.77M | -17% | $0 |
| DM | 2022-09-07 | 2022-09-06 | BSX | Mahoney Michael F | COB, Pres, CEO, Dir | M - OptEx | $9.35 | +125.8K | 1.89M | +7% | +$1.18M |
| D | 2022-09-07 | 2022-09-06 | BSX | Mahoney Michael F | COB, Pres, CEO, Dir | S - Sale+OE | $40.49 | -125.8K | 1.77M | -7% | -$5.09M |
| 2022-08-15 | 2022-08-15 | BSX | Carruthers Wendy | EVP, Human Resources | S - Sale | $42.03 | -7,500 | 117.4K | -6% | -$315.2K | |
| D | 2022-08-09 | 2022-08-08 | BSX | Mahoney Michael F | COB, Pres, CEO, Dir | S - Sale+OE | $40.97 | -125.8K | 2.13M | -6% | -$5.16M |
| DM | 2022-08-09 | 2022-08-08 | BSX | Mahoney Michael F | COB, Pres, CEO, Dir | M - OptEx | $9.35 | +125.8K | 2.22M | +6% | +$1.18M |
| 2022-08-04 | 2022-08-02 | BSX | Connors Nelda J | Dir | S - Sale | $41.58 | -16.1K | 4,877 | -77% | -$668.9K | |
| D | 2022-08-03 | 2022-08-02 | BSX | Monson Jonathan | SVP, CAO, Gbl Ctrl | F - Tax | $41.46 | -320 | 32.6K | -1.0% | -$13.3K |
| D | 2022-08-03 | 2022-08-02 | BSX | Monson Jonathan | SVP, CAO, Gbl Ctrl | M - OptEx | $0.00 | +1,089 | 32.9K | +3% | $0 |
| 2022-08-03 | 2022-08-01 | BSX | Thepaut Eric Francis Yves | EVP, Pres, Eur, Mid-East, Afr | S - Sale | $40.99 | -20.7K | 72.5K | -22% | -$847.5K | |
| 2022-07-18 | 2022-07-18 | BSX | Carruthers Wendy | EVP, Human Resources | S - Sale | $38.00 | -7,500 | 124.9K | -6% | -$285.0K | |
| D | 2022-07-06 | 2022-07-01 | BSX | Brown Vance R | SVP, GC, Corp. Sec | M - OptEx | $0.00 | +4,035 | 36.8K | +12% | $0 |
| D | 2022-07-06 | 2022-07-01 | BSX | Brown Vance R | SVP, GC, Corp. Sec | F - Tax | $38.01 | -1,185 | 35.6K | -3% | -$45.0K |
| D | 2022-07-06 | 2022-07-01 | BSX | Monson Jonathan | SVP, CAO, Gbl Ctrl | F - Tax | $38.01 | -214 | 31.8K | -0.7% | -$8,134 |
| D | 2022-07-06 | 2022-07-01 | BSX | Monson Jonathan | SVP, CAO, Gbl Ctrl | M - OptEx | $0.00 | +728 | 32.0K | +2% | $0 |
| 2022-06-27 | 2022-06-24 | BSX | Carruthers Wendy | EVP, Human Resources | S - Sale | $38.00 | -7,500 | 132.4K | -5% | -$285.0K | |
| 2022-05-17 | 2022-05-16 | BSX | Carruthers Wendy | EVP, Human Resources | S - Sale | $39.43 | -7,500 | 139.9K | -5% | -$295.7K | |
| 2022-05-09 | 2022-05-05 | BSX | Dockendorff Charles J | Dir | A - Grant | $0.00 | +4,877 | 17.1K | +40% | $0 | |
| 2022-05-06 | 2022-05-05 | BSX | Zane Ellen M | Dir | A - Grant | $0.00 | +4,877 | 41.7K | +13% | $0 | |
| M | 2022-05-06 | 2022-05-05 | BSX | WICHMANN DAVID S | Dir | A - Grant | $0.00 | +7,613 | 29.9K | +34% | $0 |
| 2022-05-06 | 2022-05-05 | BSX | LUDWIG EDWARD J | Dir | A - Grant | $0.00 | +4,877 | 41.4K | +13% | $0 | |
| 2022-05-06 | 2022-05-05 | BSX | Sununu John E | Dir | A - Grant | $0.00 | +4,877 | 45.8K | +12% | $0 |
Purchase Sale Sale after option exercise All abbreviations